Top

Reactions Weekly

Published in:

01-01-2023 | Cerebral Sinus Venous Thrombosis | Case report

Fulvestrant/letrozole/ribociclib

Thromboembolic events: 6 case reports

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Abdel-Razeq H, et al. Thromboembolic Events in Patients with HER2-Negative, Hormone Receptor-Positive, Metastatic Breast Cancer Treated with Ribociclib Combined with Letrozole or Fulvestrant: A Real-World Data. Cancer Management and Research 14: 1033-1041, 2022. Available from: URL: http://doi.org/10.2147/CMAR.S353584

Title: Fulvestrant/letrozole/ribociclib
Thromboembolic events: 6 case reports
Publication date: 01-01-2023
Publisher: Springer International Publishing
Keywords: Cerebral Sinus Venous Thrombosis
Breast Cancer
Breast Cancer
Thrombosis
Heparin
Letrozole
Fulvestrant
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-31631-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Fulvestrant/letrozole/ribociclib

Thromboembolic events: 6 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Dabigatran etexilate/heparin

Linezolid

Amoxicillin/clavulanic acid/gentamicin

Multiple drugs

Carfilzomib/nirmatrelvir+ritonavir

Tozinameran